Obesity Drug Market 2026 – 2030: Why the Next Battle Goes Beyond GLP-1
The next battle in obesity treatment is no longer simply GLP-1 vs. GLP-1. Between 2026 and 2030, competition is likely to be defined by a …
To give accurate information is our responsibly.
The next battle in obesity treatment is no longer simply GLP-1 vs. GLP-1. Between 2026 and 2030, competition is likely to be defined by a …
Saudi Arabia’s biotechnology opportunity is no longer simply about selling innovative medicines into a growing healthcare system. The bigger opportunity is being created around local …
China is becoming one of the most strategically important markets for antibody-drug conjugates (ADCs) as oncology treatment moves toward increasingly targeted therapies. A combination of …
The APAC point-of-care medical imaging market is entering an important phase of transformation as healthcare providers increasingly adopt portable, handheld, wireless and AI-enabled imaging technologies. …
The U.S. topical drugs landscape is entering a new phase of growth as pharmaceutical companies focus on targeted drug delivery, patient-friendly formulations, dermatology innovation, and …
WAINUA (eplontersen), developed by Ionis Pharmaceuticals and AstraZeneca, has established itself as an important RNA-targeted therapy for hereditary transthyretin-mediated amyloidosis with polyneuropathy (ATTRv-PN). But the …
ABA therapy practices are becoming increasingly technology-driven as providers manage larger caseloads, more complex scheduling requirements, insurance processes, clinical documentation, and multi-location operations. Software is …
For BCBAs running an ABA clinic, software has become much more than a tool for recording therapy data. Today’s ABA practices need technology to manage …
Biotech companies sourcing high-purity bulk biological reagents need more than a supplier with a large catalog. For applications ranging from drug discovery and cell culture …
Choosing the “best” commercial allergy diagnostic platform depends on what a laboratory, hospital, or allergy clinic needs most: test menu breadth, automation, throughput, multiplex testing, …